Cargando…

Melatonin/Nrf2/NLRP3 Connection in Mouse Heart Mitochondria during Aging

Aging is a major risk for cardiovascular diseases (CVD). Age-related disorders include oxidative stress, mitochondria dysfunction, and exacerbation of the NF-κB/NLRP3 innate immune response pathways. Some of the molecular mechanisms underlying these processes, however, remain unclear. This study tes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernández-Ortiz, Marisol, Sayed, Ramy K. A., Fernández-Martínez, José, Cionfrini, Antonia, Aranda-Martínez, Paula, Escames, Germaine, de Haro, Tomás, Acuña-Castroviejo, Darío
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760557/ https://www.ncbi.nlm.nih.gov/pubmed/33260800 http://dx.doi.org/10.3390/antiox9121187

Ejemplares similares

The Impact of Melatonin and NLRP3 Inflammasome on the Expression of microRNAs in Aged Muscle
por: Sayed, Ramy KA, et al.
Publicado: (2021)

The Impact of Melatonin Supplementation and NLRP3 Inflammasome Deletion on Age-Accompanied Cardiac Damage
por: Sayed, Ramy K. A., et al.
Publicado: (2021)

Lack of retinoid acid receptor-related orphan receptor alpha accelerates and melatonin supplementation prevents testicular aging
por: Sayed, Ramy K. A., et al.
Publicado: (2020)

Age and Chronodisruption in Mouse Heart: Effect of the NLRP3 Inflammasome and Melatonin Therapy
por: Fernández-Ortiz, Marisol, et al.
Publicado: (2022)

Chronodisruption and Loss of Melatonin Rhythm, Associated with Alterations in Daily Motor Activity and Mitochondrial Dynamics in Parkinsonian Zebrafish, Are Corrected by Melatonin Treatment
por: Aranda-Martínez, Paula, et al.
Publicado: (2023)

The Role of Mitochondria in Brain Aging and the Effects of Melatonin
por: Escames, Germaine, et al.
Publicado: (2010)

The Zebrafish, an Outstanding Model for Biomedical Research in the Field of Melatonin and Human Diseases
por: Aranda-Martínez, Paula, et al.
Publicado: (2022)

Role of Melatonin in Cancer: Effect on Clock Genes
por: Rodríguez-Santana, César, et al.
Publicado: (2023)

Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases
por: López, Ana, et al.
Publicado: (2017)

Protective Effects of Melatonin on the Skin: Future Perspectives
por: Rusanova, Iryna, et al.
Publicado: (2019)

Understanding the Mechanism of Action of Melatonin, Which Induces ROS Production in Cancer Cells
por: Florido, Javier, et al.
Publicado: (2022)

Oral Mucositis: Melatonin Gel an Effective New Treatment
por: Abdel Moneim, Ahmed Esmat, et al.
Publicado: (2017)

Analysis of Plasma MicroRNAs as Predictors and Biomarkers of Aging and Frailty in Humans
por: Rusanova, Iryna, et al.
Publicado: (2018)

The Relationship between Clock Genes, Sirtuin 1, and Mitochondrial Activity in Head and Neck Squamous Cell Cancer: Effects of Melatonin Treatment
por: Rodríguez-Santana, César, et al.
Publicado: (2023)

Melatonin protects rats from radiotherapy-induced small intestine toxicity
por: Fernández-Gil, Beatriz, et al.
Publicado: (2017)

Melatonin Targets Metabolism in Head and Neck Cancer Cells by Regulating Mitochondrial Structure and Function
por: Guerra-Librero, Ana, et al.
Publicado: (2021)

The NLRP3 inflammasome: contributions to inflammation-related diseases
por: Chen, Ying, et al.
Publicado: (2023)

Melatonin drives apoptosis in head and neck cancer by increasing mitochondrial ROS generated via reverse electron transport
por: Florido, Javier, et al.
Publicado: (2022)

A phase II, single‐center, double‐blind, randomized placebo‐controlled trial to explore the efficacy and safety of intravenous melatonin in surgical patients with severe sepsis admitted to the intensive care unit
por: Mansilla‐Roselló, Alfonso, et al.
Publicado: (2022)

A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): a structured summary of a study protocol for a randomized controlled trial
por: Rodríguez-Rubio, Miguel, et al.
Publicado: (2020)

Melatonin Treatment Reduces Oxidative Damage and Normalizes Plasma Pro-Inflammatory Cytokines in Patients Suffering from Charcot-Marie-Tooth Neuropathy: A Pilot Study in Three Children
por: Chahbouni, Mariam, et al.
Publicado: (2017)

Melatonin Enhances Cisplatin and Radiation Cytotoxicity in Head and Neck Squamous Cell Carcinoma by Stimulating Mitochondrial ROS Generation, Apoptosis, and Autophagy
por: Fernandez-Gil, Beatriz I., et al.
Publicado: (2019)

Effect of 5-Azacitidine Treatment on Redox Status and Inflammatory Condition in MDS Patients
por: Montes, Paola, et al.
Publicado: (2022)

Rapamycin administration is not a valid therapeutic strategy for every case of mitochondrial disease
por: Barriocanal-Casado, Eliana, et al.
Publicado: (2019)

β‐RA reduces DMQ/CoQ ratio and rescues the encephalopathic phenotype in Coq9 (R239X) mice
por: Hidalgo‐Gutiérrez, Agustín, et al.
Publicado: (2018)

Accumulation of Exogenous Amyloid-Beta Peptide in Hippocampal Mitochondria Causes Their Dysfunction: A Protective Role for Melatonin
por: Rosales-Corral, Sergio, et al.
Publicado: (2012)

Melatonin in Antinociception: Its Therapeutic Applications
por: Srinivasan, Venkatramanujam, et al.
Publicado: (2012)

BSCI-27. MELATONIN REDUCES MALIGNANCY OF BREAST CANCER BRAIN METASTATIC CELLS
por: Gil, Beatriz Fernandez, et al.
Publicado: (2019)

Identification of PIK3CG as a hub in septic myocardial injury using network pharmacology and weighted gene co‐expression network analysis
por: Liu, Qiong, et al.
Publicado: (2022)

Reduction in the levels of CoQ biosynthetic proteins is related to an increase in lifespan without evidence of hepatic mitohormesis
por: Rodríguez-Hidalgo, María, et al.
Publicado: (2018)

Melatonin Mitigates Mitochondrial Meltdown: Interactions with SIRT3
por: Reiter, Russel J., et al.
Publicado: (2018)

CoQ deficiency causes disruption of mitochondrial sulfide oxidation, a new pathomechanism associated with this syndrome
por: Luna‐Sánchez, Marta, et al.
Publicado: (2016)

DDRE-33. MELATONIN AS A MASTER METABOLIC SWITCH FOR GLIOBLASTOMA
por: Fernandez-Gil, Beatriz Irene, et al.
Publicado: (2021)

Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?
por: Romero, Alejandro, et al.
Publicado: (2020)

The clinical heterogeneity of coenzyme Q(10) deficiency results from genotypic differences in the Coq9 gene
por: Luna-Sánchez, Marta, et al.
Publicado: (2015)

Role of c-miR-21, c-miR-126, Redox Status, and Inflammatory Conditions as Potential Predictors of Vascular Damage in T2DM Patients
por: López-Armas, Gabriela C., et al.
Publicado: (2022)

Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis
por: Reiter, Russel J., et al.
Publicado: (2017)

Mitochondria and the NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis
por: Torres, Sandra, et al.
Publicado: (2022)

Melatonin Treatment Triggers Metabolic and Intracellular pH Imbalance in Glioblastoma
por: Fernandez-Gil, Beatriz I., et al.
Publicado: (2022)

The Melatonin Analog IQM316 May Induce Adult Hippocampal Neurogenesis and Preserve Recognition Memories in Mice
por: Figueiro-Silva, Joana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dv799rjbihp8sm0796hiludih2